Botulinum Toxin Wrinkle-Reducer
Dysport, a botulinum toxin wrinkle-reducer very similar to Botox Cosmetic, and was FDA-approved for use in the U.S. in May of 2009. Dysport is a common wrinkle treatment throughout Europe and other parts of the world.
While Dysport and Botox are relatively comparable, physicians sometimes prefer one over the other in certain facial areas due to differences in the onset of results and spread of effect. Dysport is slightly faster-acting and has a greater “spread” (giving a more “natural” look), while Botox tends to remain more localized, allowing for greater precision and predictability in the treatment area but possibly requiring more injections in the course of treatment.